These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Clinical studies of tazobactam/piperacillin (TAZ/PIPC) in pediatric patients]. Waga S, Yokoyama M, Tsushima T, Chiba C, Saito T, Okamoto T, Asuka T, Kitazawa J, Tateyama N, Sato Y, Takahashi Y. Jpn J Antibiot; 1998 May; 51(5):305-18. PubMed ID: 9693964 [Abstract] [Full Text] [Related]
7. Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants). Higashitani F, Nishida K, Hyodo A, Inoue M. J Antibiot (Tokyo); 1995 Sep; 48(9):1027-33. PubMed ID: 7592048 [Abstract] [Full Text] [Related]
11. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia]. Oizumi K, Ohno T, Kawahara M, Kawaguchi S, Saisho M, Mitutake Y, Saito A, Tomizawa M, Koike T, Takebe K. Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313 [Abstract] [Full Text] [Related]
16. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis]. Fukasawa C, Hoshino T, Kutsuna S, Sawada K, Sato H, Ishiwada N. Kansenshogaku Zasshi; 2013 Sep; 87(5):590-5. PubMed ID: 24195168 [Abstract] [Full Text] [Related]
17. [A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections]. Oizumi K, Kawahara M, Kawaguchi S, Sigematsu H, Tanaka F, Sano N, Saito A, Hiraga Y, Ohmichi M, Inoue H. Jpn J Antibiot; 1995 Apr; 48(4):482-513. PubMed ID: 7783314 [Abstract] [Full Text] [Related]